Similarly, when patients were stratified according to the underlying liver disease etiology (e.g., HBV, HCV, alcoholic liver disease, NAFLD, cryptogenic), no significant differences were detected in baseline HALP, GPR, or FIB-4 values (all p > 0.05). This evidence concerns the gene NAT10 and metabolic dysfunction-associated steatotic liver disease.